Log in to save to my catalogue

Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild c...

Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7816207

Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus

About this item

Full title

Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus

Publisher

England: John Wiley & Sons, Inc

Journal title

CNS neuroscience & therapeutics, 2021-02, Vol.27 (2), p.149-162

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Mild cognitive impairment (MCI) is a neurocognitive state between normal cognitive aging and dementia, with evidence of neuropsychological changes but insufficient functional decline to warrant a diagnosis of dementia. Individuals with MCI are at increased risk for progression to dementia; and an appreciable proportion display neurops...

Alternative Titles

Full title

Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7816207

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7816207

Other Identifiers

ISSN

1755-5930

E-ISSN

1755-5949

DOI

10.1111/cns.13536

How to access this item